
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Atopic eczema in adulthood and mortality: UK population-based cohort study, 1998-2016”, J Allergy Clin Immunol, 2021.
, “Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study”, Lancet Digit Health, 2021.
, “Inflammatory Skin Diseases and the Risk of Chronic Kidney Disease - Population-Based Case-control and Cohort analyses”, Br J Dermatol, 2021.
, “Using electronic health records to inform trial feasibility in a rare autoimmune blistering skin disease in England”, BMC Med Res Methodol, vol. 21, p. 22, 2021.
, “The association between partner bereavement and melanoma: cohort studies in the U.K. and Denmark”, Br J Dermatol, 2020.
, “Atopic eczema and obesity: a population-based study”, Br J Dermatol, 2020.
, “Incidence of acute complications of herpes zoster among immunocompetent adults in England: a matched cohort study using routine health data”, Br J Dermatol, 2020.
, “Incidence, prevalence, and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study”, Br J Dermatol, 2020.
, “Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data”, Bmj, vol. 368, p. l6987, 2020.
, “Risk of Hospitalisation and Death due to Infection in People with Psoriasis: a Population-based Cohort Study using the Clinical Practice Research Datalink”, Br J Dermatol, 2020.
, “Validation study of bullous pemphigoid and pemphigus vulgaris recording in routinely collected electronic primary healthcare records in England”, BMJ Open, vol. 10, p. e035934, 2020.
, “Atopic eczema and fracture risk in adults: A population-based cohort study”, J Allergy Clin Immunol, 2019.
, “Atopic eczema in adulthood and risk of depression and anxiety: a population-based cohort study”, J Allergy Clin Immunol Pract, 2019.
, “Partner Bereavement and Detection of Dementia: A UK-Based Cohort Study Using Routine Health Data”, J Alzheimers Dis, 2019.
, , “Effectiveness of herpes zoster vaccination in an older United Kingdom population”, Vaccine, vol. 36, pp. 2371-2377, 2018.
, “Inequalities in zoster disease burden: a population-based cohort study to identify social determinants using linked data from the U.K. Clinical Practice Research Datalink”, Br J Dermatol, vol. 178, pp. 1324-1330, 2018.
, “Mood Disorders and Risk of Herpes Zoster in 2 Population-Based Case-Control Studies in Denmark and the United Kingdom”, Am J Epidemiol, vol. 187, pp. 1019-1028, 2018.
, “Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study”, Bmj, vol. 361, p. k1786, 2018.
, “Zoster vaccination inequalities: A population based cohort study using linked data from the UK Clinical Practice Research Datalink”, PLoS One, vol. 13, p. e0207183, 2018.
, “Herpes zoster risk after 21 specific cancers: population-based case-control study”, Br J Cancer, vol. 116, pp. 1643-1651, 2017.
, “Partner Bereavement and Risk of Herpes Zoster: Results from Two Population-Based Case-Control Studies in Denmark and the United Kingdom”, Clin Infect Dis, vol. 64, pp. 572-579, 2017.
, “Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink”, PLoS Med, vol. 13, p. e1002037, 2016.
, “Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study”, Neurology, vol. 87, pp. 94-102, 2016.
, “Chickenpox and risk of stroke: a self-controlled case series analysis”, Clin Infect Dis, vol. 58, pp. 61-8, 2014.
, “Quantification of risk factors for herpes zoster: population based case-control study”, Bmj, vol. 348, p. g2911, 2014.
, “Risk of stroke following herpes zoster: a self-controlled case-series study”, Clin Infect Dis, vol. 58, pp. 1497-503, 2014.
, “Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study”, J Invest Dermatol, vol. 132, pp. 2166-70, 2012.
, “Prescription of antiviral therapy after herpes zoster in general practice: who receives therapy?”, Br J Gen Pract, vol. 62, pp. e808-14, 2012.
, “The relationship between neurological disease and bullous pemphigoid: a population-based case-control study”, J Invest Dermatol, vol. 131, pp. 631-6, 2011.
,